A Randomized, Placebo-Controlled, Multi-Site Phase 2 Stu

Project: Research project

Project Details

Description

A Randomized, Placebo-Controlled, Multi-Site Phase 2 Study Evaluating the Safety and Efficacy of Preemptive Treatment with CMX001 for the Prevention of Adenovirus Disease Following Hematopoietic Stem Cell Transplantation (The ADV HALT Trial) Amendment 3
StatusFinished
Effective start/end date10/31/1112/31/13

Funding

  • Chimerix, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.